Manufacturer record
Maxtra Laboratories TIF Industrial Park: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Maxtra Laboratories TIF Industrial Park (Telangana) was declared Not of Standard Quality in November 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MXS9027, Dilabron LS Syrup Ambroxol HCL, Levosalbutamol Sulphate &Guaiphenesin Syrup (exp Jun 2026). State Lab Drugs Control Laboratory, Telangana (state lab) found it not of standard quality: MISBRANDED The label should be mentioned as Levosalbutamol Sulphate IP equivalent to Levosalbutamol. In the composition the label is. Listed in the November 2024 alert.
Records by type
1 record linked to Maxtra Laboratories TIF Industrial Park in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dilabron LS Syrup Ambroxol HCL, Levosalbutamol Sulphate &Guaiphenesin Syrup | Batch MXS9027Mfg Jul 2024 · Exp Jun 2026 | MISBRANDED The label should be mentioned as Levosalbutamol Sulphate IP equivalent to Levosalbutamol. In the composition the label is mentioned as only Levosalbutamol Sulphate,. Hence, it is a Misbranded drug as per section 17 of Dugs and Cosmetics Act 1940.Misbranded | State Lab Drugs Control Laboratory, TelanganaState lab | Nov 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.